Interview with Martin Herzmann: Point of Care 3D Printing

blank

Martin Herzmann started his medtech career in 1999 at Brainlab and was responsible for preoperative planning software. In 2007 he joined Ziehm Imaging and worked for another eight years as Marketing Director for medical capital equipment. In 2015, he joined the Materialise Medical division as Sales Manager and was responsible for German-speaking installations of planning software and services for medical 3D printing. Since 2019, Martin Herzmann has been working as Business Development Manager at Kumovis. The company focuses on medical 3D printing with high-performance polymers and biodegradable polymers and launched the R1 3D printer in the summer 2019: a system for additive manufacturing exclusively in medical technology. Customers include both hospitals and medical technology companies. Martin will be speaking at our upcoming webinar 3D Printing for Point of Care.

Point of Care 3D Printing July 15 (3)-min

Jenny: When was the first encounter you had with 3D printing?

Martin: I remember the benefit of anatomical models in craniomaxillofacial cases back in 2005. 16 years ago, I was working on pre-operative planning software and was used to sophisticated 3D visualization on a screen. However, the haptic experience added significant value to the case.

Jenny: What inspired you to start your journey/company/career/research in 3D printing?

Martin: I am working in medical business since 1999 and was luckily always able to invent new treatment possibilities. CMF planning software with Brainlab, intraoperative 3D imaging with Ziehm, Medical 3D printing software and services with Materialise and now re-inventing medical implant manufacturing with Kumovis. Pioneering medical technologies and the joy of growth inspired me – and still inspire me today. 

Jenny: Who inspired you the most along this journey in 3D printing (bio-printing/bio-fabrication)? This can be a mentor, a patient, a celebrity, anyone basically. You can name more than one as well.

Martin: As a surgeon I thank Daniel Buchbinder who hosted the kick-off workshop for 3D planning software for CMF in New York. Florian Thieringer from Basel University also inspired me as he kept on believing in future technologies.  

Jenny: What motivates you the most for your work? 

Martin: My strong belief that 3D-printed cranial implants will help patients, reduce costs, will be manufactured in regulatory boundaries and will change healthcare in near future significantly.

Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions? 

Martin: Disruptive technologies such as Kumovis printing solutions will not conquer the market automatically. Push backs are obvious and expected, will be overcome one day but are the biggest obstacles.

Jenny: What do you think is (are) the biggest challenge(s) in 3D Printing/bio-printing? What do you think the potential solution(s) is (are)?

Martin: I believe I answered this question in 2018 and still I believe: The biggest challenge is translation from R´n´D to real application. But exactly this is one reason why I joined Kumovis: We are so close to complete this challenge and launch 3D printed cranial plates in PEEK and provide a regulatory pathway for FDA and MDR.

Jenny: If you are granted three wishes by a higher being, what would they be? 

Martin: Stop global warming, ensure a peaceful life together, die happy.

Jenny: What advice would you give to a smart driven college student in the “real world”? What bad advices you heard should they ignore? 

Martin: Whatever project you start and whatever you want to achieve: start small and grow fast.

Medical 3D Printing – An Indian Perspective on Point of Care Micro Labs

3D Printing at Point of Care

Interview with Stefan Leonhardt, Kumovis (Video and Podcast)

What does it take to bring 3D printing technology in to “mainstream” healthcare?

Cancer: What 3D Printing (Bioprinting) Can do For Oncological Care

Pricing Strategies for 3D Printing Related Medical Devices

A World of Regulation: Updates on 3D printed Medical Devices

Comments